Bill Miller's position in Bristol-Myers Squibb is currently worth $3.98M. That's 1.00% of their equity portfolio (29th largest holding). Bill Miller started to build up the position in Bristol-Myers Squibb in Q1 2024 and continued to invest until Q4 2024. Since then they sold 38.5k shares. The stake costed the investor $3.57M, netting the investor a gain of 12% so far.